Pan Z - Search Results

1

Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis.

Zhao Y, Liu J, Cai X, Pan Z, Liu J, Yin W, Chen H, Xie Z, Liang H, Wang W, Guo Z, Zhao S, Liang W, He J. Zhao Y, et al. Among authors: pan z. BMJ. 2019 Oct 7;367:l5460. doi: 10.1136/bmj.l5460. BMJ. 2019. PMID: 31591158 Free PMC article.

2

[Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].

Zhang L, Zhang Y, Li N, Xu F, Pan ZK, Guan ZZ. Zhang L, et al. Ai Zheng. 2004 Nov;23(11 Suppl):1455-8. Ai Zheng. 2004. PMID: 15566656 Clinical Trial. Chinese.

3

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].

Pan ZK, Zhang L, Zhang X, Wang X, Li N, Xu F, Chang JH, Guan ZZ. Pan ZK, et al. Ai Zheng. 2005 Aug;24(8):919-23. Ai Zheng. 2005. PMID: 16086866 Chinese.

4

[Efficacy of gefitinib on advanced non-small cell lung cancer in expanded access program (EAP)].

Zhang Y, Zhang L, Xu F, Wang ZQ, Zhao HY, Guan ZZ, Xu GC, Pan ZK. Zhang Y, et al. Ai Zheng. 2006 Dec;25(12):1561-4. Ai Zheng. 2006. PMID: 17166387 Chinese.

5

[K-RAS gene mutations in patients with non-small cell lung cancer].

Zhang Y, Pan Z, Zhang X, Xu F, Zhang L. Zhang Y, et al. Among authors: pan z. Zhongguo Fei Ai Za Zhi. 2010 Jun;13(6):602-6. doi: 10.3779/j.issn.1009-3419.2010.06.007. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20681447 Free PMC article. Chinese.

6

The alteration of T790M between 19 del and L858R in NSCLC in the course of EGFR-TKIs therapy: a literature-based pooled analysis.

Liang H, Pan Z, Wang W, Guo C, Chen D, Zhang J, Zhang Y, Tang S, He J, Liang W; written on behalf of AME Lung Cancer Cooperative Group. Liang H, et al. Among authors: pan z. J Thorac Dis. 2018 Apr;10(4):2311-2320. doi: 10.21037/jtd.2018.03.150. J Thorac Dis. 2018. PMID: 29850136 Free PMC article.

7

The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer.

Liang H, Pan Z, Cai X, Wang W, Guo C, He J, Chen Y, Liu Z, Wang B, He J, Liang W; AME Lung Cancer Cooperative Group. Liang H, et al. Among authors: pan z. Transl Lung Cancer Res. 2018 Jun;7(3):397-403. doi: 10.21037/tlcr.2018.03.16. Transl Lung Cancer Res. 2018. PMID: 30050777 Free PMC article.

8

Erratum: The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer.

Liang H, Pan Z, Cai X, Wang W, Guo C, He J, Chen Y, Liu Z, Wang B, He J, Liang W. Liang H, et al. Among authors: pan z. Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S302. doi: 10.21037/tlcr.2018.07.14. Transl Lung Cancer Res. 2018. PMID: 30393628 Free PMC article.

9

PD-(L)1 inhibitors vs. chemotherapy vs. their combination in front-line treatment for NSCLC: An indirect comparison.

Liang H, Liu Z, Cai X, Pan Z, Chen D, Li C, Chen Y, He J, Liang W. Liang H, et al. Among authors: pan z. Int J Cancer. 2019 Dec 1;145(11):3011-3021. doi: 10.1002/ijc.32366. Epub 2019 May 10. Int J Cancer. 2019. PMID: 31018251

10

Association between certain non-small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death-ligand 1 inhibition.

Liang W, Guo M, Pan Z, Cai X, Li C, Zhao Y, Liang H, Yang H, Wang Z, Chen W, Xu C, Yang X, Sun J, He P, Gu X, Yin W, He J. Liang W, et al. Among authors: pan z. Cancer Sci. 2019 Jun;110(6):2014-2021. doi: 10.1111/cas.14032. Epub 2019 May 22. Cancer Sci. 2019. PMID: 31033100 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,864 results

Search Page

Filters